Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
2 NC counties are under alert, including Johnston County.
Breaking News
Food truck hit by gunfire in Raleigh
Program
It's time for football! Tune to WRAL-TV to catch all the Week 1 highlights on Football Friday
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Recursion Pharmaceuticals Inc Cl A
(NQ:
RXRX
)
7.810
+0.460 (+6.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,388,153
Open
7.460
Bid (Size)
7.810 (1)
Ask (Size)
7.840 (2)
Prev. Close
7.350
Today's Range
7.260 - 7.842
52wk Range
4.970 - 15.74
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
How Is The Market Feeling About Recursion Pharmaceuticals?
August 23, 2024
Via
Benzinga
The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why.
August 18, 2024
Merging with a former rival will bolster its capabilities.
Via
The Motley Fool
Performance
YTD
-20.87%
-20.87%
1 Month
N/A
N/A
3 Month
-14.74%
-14.74%
6 Month
-41.59%
-41.59%
1 Year
-8.87%
-8.87%
More News
Read More
Is Recursion Pharmaceuticals Stock a Buy?
August 17, 2024
Via
The Motley Fool
AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD
August 14, 2024
Via
Talk Markets
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
August 14, 2024
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Recursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT
August 08, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th
August 05, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
August 14, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks
August 13, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RXRX, GVP, OBDE, OBDC on Behalf of Shareholders
August 12, 2024
From
Halper Sadeh LLC
Via
GlobeNewswire
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
August 12, 2024
Via
The Motley Fool
Is Recursion Pharmaceuticals a Buy Ahead of Its Merger With Exscientia?
August 11, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI-Powered Drug Discovery Firm Exscientia To Merge With Nvidia-Partner Recursion Pharmaceuticals
August 08, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
RXRX Stock Earnings: Recursion Pharmaceuticals Meets EPS, Beats Revenue for Q2 2024
August 08, 2024
Via
InvestorPlace
CORRECTION - Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
RXRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Recursion Pharmaceuticals, Inc. Is Fair to Shareholders
August 08, 2024
From
Halper Sadeh LLC
Via
Business Wire
Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities
August 08, 2024
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Recursion Provides Business Updates and Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Is Recursion Pharmaceuticals a Millionaire-Maker?
August 06, 2024
Via
The Motley Fool
99.9% of Nvidia's $380 Million Investment Portfolio Has Been Put to Work in These 4 Artificial Intelligence (AI)-Inspired Stocks
July 31, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD
July 30, 2024
Via
Talk Markets
Down About 47% This Year: Is Recursion Pharmaceuticals a Buy on the Dip?
July 27, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
25 Best Artificial Intelligence Stocks to Buy Right Now
July 25, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
These 7 AI Stocks Were Major Movers On Monday/Tuesday - Here's Why
July 24, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Millionaire-Maker Artificial Intelligence (AI) Stocks
July 18, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.